{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-071247","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2023-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.211418+00:00","generated_at":"2026-06-11T02:57:08.426821+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Blue Water Biotech receives Nasdaq deficiency notice for late Q2 2023 10-Q filing","bullets":["Received Nasdaq deficiency notice on August 22, 2023 for failing to timely file Form 10-Q for quarter ended June 30, 2023.","Has 60 calendar days to submit a compliance plan; Nasdaq may grant extension until February 20, 2024.","Company cites ongoing review of employee expenditures as reason for delay; no timeline for filing given.","Notice does not immediately affect listing or trading of BWV common stock on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-071247","json":"https://secwatch.observer/filing/0001213900-23-071247.json","markdown":"https://secwatch.observer/filing/0001213900-23-071247.md","text":"https://secwatch.observer/filing/0001213900-23-071247.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023071247/0001213900-23-071247-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023071247/ea184317-8k_bluewater.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:57:08.426821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1aae7c0e1cad4d4551fcfdae94cc6da9ed336f3c","claim":"Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"August 22, 2023, Blue Water Biotech, Inc. (the “ Company ”) received a deficiency notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Listing Rules ”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file its quarterly report on Form 10-Q for the quarter ended June 30, 2023 (the “ 10-Q ”). Consistent with the Listing Rules, the Company has 60 calendar days from the date of the Notice to provide Nasdaq with a specific plan to achieve and sustain compliance with","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023071247/0001213900-23-071247-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}